Summary & Overview
CPT 0672T: Vaginal Cryogenic and Radiofrequency Treatment for Urinary Incontinence
CPT code 0672T defines a vaginal probe procedure combining cryogenic cooling and radiofrequency energy to stimulate collagen and remodel tissue for treatment of urinary incontinence. As an emerging device- and procedure-based therapy in female pelvic medicine, this code captures a modern, minimally invasive alternative to surgical interventions and conservative measures. Nationally, its adoption influences outpatient service patterns, device utilization, and payer coverage decisions for pelvic floor disorders.
Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines typical coverage elements and reimbursement considerations across commercial and federal payers and highlights coding and billing implications for ambulatory settings.
Readers will find: a concise clinical context for 0672T, the expected site-of-service and service type, an overview of how major payers address the procedure, and practical benchmarking and policy-relevant points relevant to billing teams and administrators. Data not available in the input is noted where applicable, and the focus remains on national policy and billing context rather than state-specific rules.
Billing Code Overview
CPT code 0672T describes a minimally invasive intracavitary procedure in which a provider inserts a small probe into the vagina that delivers a combination of cryogen cooling and radiofrequency energy to vaginal tissues. The treatment is intended to stimulate collagen production and remodel connective tissue to address urinary incontinence (unintentional passing of urine).
-
Service type: Minimally invasive vaginal thermal/cryogenic tissue remodeling procedure targeting pelvic floor and periurethral tissues
-
Typical site of service: Ambulatory surgical center or physician office procedure room
Clinical & Coding Specifications
Clinical Context
A 52-year-old parous woman presents to a urogynecology clinic with several years of stress-predominant urinary incontinence characterized by leakage with coughing, sneezing, and exertion. Conservative measures including pelvic floor physical therapy and pessary use provided partial relief but symptoms persist and negatively impact quality of life. After counseling regarding non-surgical options, the patient elects a minimally invasive, office-based ablation and remodeling procedure using a transvaginal cryogen-cooled radiofrequency probe to stimulate collagen remodeling in vaginal and periurethral tissues to reduce urethral hypermobility and improve continence.
The clinical workflow includes:
-
Pre-procedure evaluation: focused history, pelvic exam, urinalysis to exclude infection, and assessment of pelvic organ support and urethral mobility. Discussion of alternatives, risks, benefits, and informed consent are completed.
-
Procedure preparation: patient positioned in lithotomy on a procedure table in an outpatient clinic or ambulatory surgery center. Local anesthesia with or without sedation is administered per provider preference. A sterile transvaginal probe is placed and multiple treatment cycles are delivered circumferentially along targeted zones to thermally stimulate collagen production.
-
Immediate post-procedure care: brief observation for bleeding or vasovagal symptoms, discharge instructions on activity restrictions and avoidance of intravaginal intercourse for the recommended healing interval. Follow-up visit scheduled to assess symptom improvement and complications.
-
Typical site of service: outpatient clinic procedure room, ambulatory surgery center, or office-based gynecologic procedure suite.
-
Service type: minimally invasive, transvaginal cryothermal and radiofrequency tissue remodeling for treatment of urinary incontinence.